Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis
about
Innate immunity in inflammatory bowel disease: a disease hypothesisFunction of Nod-like receptors in microbial recognition and host defenseRole of regulatory T cell in the pathogenesis of inflammatory bowel diseaseEffector and memory T cell responses to commensal bacteriaThe cooperation between the autophagy machinery and the inflammasome to implement an appropriate innate immune response: do they regulate each other?Cellular and molecular regulation of innate inflammatory responsesPeptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gammaEvidence for the involvement of NOD2 in regulating colonic epithelial cell growth and survivalInflammatory bowel diseaseToll-like receptor 2 (TLR2)-TLR9 crosstalk dictates IL-12 family cytokine production in microglia.The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis.Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance.Molecular control of steady-state dendritic cell maturation and immune homeostasis.Comorbidities of hidradenitis suppurativa (acne inversa).Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitisNOD-like receptors in intestinal homeostasis and epithelial tissue repair.Blowing on embers: commensal microbiota and our immune system.Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileumToll-like receptors in inflammatory bowel diseases: a decade later.Peptidoglycan recognition protein 3 and Nod2 synergistically protect mice from dextran sodium sulfate-induced colitisNucleotide-binding oligomerization domain 2 and Toll-like receptor 2 function independently in a murine model of arthritis triggered by intraarticular peptidoglycanHost and gut microbiota symbiotic factors: lessons from inflammatory bowel disease and successful symbionts.Nod2: a key regulator linking microbiota to intestinal mucosal immunity.IκB kinase α phosphorylation of TRAF4 downregulates innate immune signaling.Reactive oxygen species regulate caspase-11 expression and activation of the non-canonical NLRP3 inflammasome during enteric pathogen infection.Toll-like receptor 2 deficiency results in impaired antibody responses and septic shock during Borrelia hermsii infection.Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future?Loss of TLR2 worsens spontaneous colitis in MDR1A deficiency through commensally induced pyroptosis.Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting ProteinsNOD1 and NOD2: signaling, host defense, and inflammatory disease.NOD1 expression in the eye and functional contribution to IL-1beta-dependent ocular inflammation in mice.Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.NOD2 deficiency results in increased susceptibility to peptidoglycan-induced uveitis in miceEmerging significance of NLRs in inflammatory bowel disease.Salmonella enterica serovar Typhimurium ΔmsbB triggers exacerbated inflammation in Nod2 deficient mice.Macrophages Are Phenotypically and Functionally Diverse across Tissues in Simian Immunodeficiency Virus-Infected and Uninfected Asian Macaques.The fundamental basis of inflammatory bowel disease.Pathogenesis of Crohn's diseaseSurface-Associated Lipoproteins Link Enterococcus faecalis Virulence to Colitogenic Activity in IL-10-Deficient Mice Independent of Their Expression LevelsInterrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.
P2860
Q22252859-D1FE37FA-5E5A-48A7-82BB-C0D189591FC3Q24647448-392A6430-6C93-45FE-B1E4-DA1640A7CD38Q26768560-DD0942FB-E8FE-4470-9AB2-9D0322E0C44EQ27024742-958AFAB8-CDE8-4091-A373-D9E590D4B900Q27026138-A2A0D8DA-23AD-4B42-AE9F-7B6C11FFB6A0Q28079497-F20813A7-EB29-459B-B352-FC0A26B4EF38Q28587904-E6703D95-1F1F-4A9F-9102-26DB4FE3F6C3Q28594839-3FD868C1-0F7B-44CA-8403-E6C4CF405346Q29615500-428F5DCB-23F0-4822-888A-F5AF7CEE6AB3Q30423121-1F56D6AD-2639-4530-AE03-77711092D6B0Q33594436-4CD747AF-93D5-445B-B2B2-63ABC4E62340Q33841037-17E6F0DF-4D24-4AAA-B8CA-D73FE979FBDFQ33882051-78D4194C-40E1-4C9C-BC95-AE6AF3FB8A00Q33890939-16D747F6-E425-4D18-BB8A-6C58932AED61Q33902387-FACF3846-DE66-4862-897D-957856BCED11Q33907548-E1E697CA-9B3B-4169-BE31-5970BBBD6650Q33958449-7DDBD617-42EC-40CA-8CDB-7810845A3B70Q34093119-20EDC32B-919B-4736-8971-840A739938F6Q34134813-4ADF6CFF-4D3C-47F8-A5B6-DFC215C2A7A3Q34146736-3192ED19-C1A2-4420-B996-3970005B503FQ34154459-1E70AD21-09A0-43A1-830F-52AFF90095E2Q34164041-BA9EBEE2-C5B6-49EE-B5AE-6A29810FFF25Q34210133-2CE70310-5FED-4FB8-9DE2-97E8C5D8DC8CQ34252506-A8016C64-8BA2-400D-A24F-30DD7FFA60F5Q34257920-EF4BA0E8-49C8-4E62-A46B-FDC383FA07C1Q34290670-1A7EEEE2-0E92-4321-95A9-47AFBDBE935EQ34307355-24397D72-8EE8-4027-B55C-1D3BBE66D889Q34342336-C6C705E0-7167-41A5-9A77-4ABBEFE3535FQ34544054-D4D23D43-224A-457B-81CF-73DD1F096017Q34745603-756AD6CD-378B-4C1C-AA00-9448FAB8FF69Q34908481-9CF48ECA-D392-4413-8772-C1F9FE3A6012Q35190723-E8D0FEDE-CF48-434D-BF5B-7EE21690DDD7Q35220891-BA704E28-F5A0-4054-9410-EF5C806E1473Q35414220-2B4BD8F2-FA90-484F-83F4-E073641FC4E5Q35448563-96690680-BA69-4E91-80A8-06A55C5BDAF0Q35641157-5ED0EFFD-A462-4483-9E3B-8085064B7188Q35649436-F11381ED-4814-4966-9B65-036C714004ACQ35659341-F05E40AA-E3F4-46B7-BBD2-1FBDE30238D5Q35661462-BF8B192A-DFD3-4215-ACC1-6511F4F50821Q35714248-D997EDBE-0123-4C1C-9291-7230CA7F97C4
P2860
Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis
description
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im September 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/09/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/09/01)
@nl
наукова стаття, опублікована у вересні 2006
@uk
مقالة علمية (نشرت في سبتمبر 2006)
@ar
name
Nucleotide binding oligomeriza ...... on of antigen-specific colitis
@ast
Nucleotide binding oligomeriza ...... on of antigen-specific colitis
@en
Nucleotide binding oligomeriza ...... on of antigen-specific colitis
@nl
type
label
Nucleotide binding oligomeriza ...... on of antigen-specific colitis
@ast
Nucleotide binding oligomeriza ...... on of antigen-specific colitis
@en
Nucleotide binding oligomeriza ...... on of antigen-specific colitis
@nl
prefLabel
Nucleotide binding oligomeriza ...... on of antigen-specific colitis
@ast
Nucleotide binding oligomeriza ...... on of antigen-specific colitis
@en
Nucleotide binding oligomeriza ...... on of antigen-specific colitis
@nl
P2093
P921
P3181
P1433
P1476
Nucleotide binding oligomeriza ...... on of antigen-specific colitis
@en
P2093
Atsushi Kitani
Ivan J. Fuss
Peter J. Murray
Tomohiro Watanabe
Warren Strober
Yoshio Wakatsuki
P304
P3181
P356
10.1016/J.IMMUNI.2006.06.018
P407
P577
2006-09-01T00:00:00Z